Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
Home > Pressemitteilung: Major Progress in the Development of ...
Würzburg researchers present a new strategy against the life-threatening fungus Aspergillus fumigatus. They combine RNA ...
The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...
The Indian government has announced several initiatives in the Union Budget 2025-26 to strengthen cancer care and improve ...
It has also started a 225-subject phase 3 trial called OASIS, comparing treatment with olorofim to Astellas' AmBisome (liposomal amphotericin B) in invasive aspergillosis, which should generate ...
Along with the phase 2b study, F2G and Shionogi are also running a phase 3 trial called OASIS that is comparing olorofim to Astellas’ AmBiome (liposomal amphotericin B) – a standard therapy ...
and rigors associated with anesthesia or drug therapy (typically chemotherapy or amphotericin B). Interventions were made for all patients receiving meperidine for pain management. Almost all ...
The limited amount of research devoted to the nebulization of the drugs listed above and the lack of definitive preparation guidelines presented in the research can lead to confusion in deciding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback